FDA sets acceptable intake limits for nitrosamines in drugs
Regulatory NewsJoanne S. Eglovitch
APIsChemistry, Manufacturing and Controls (CMC)ComplianceNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management